To further elucidate the mechanism by which FADS2 regulates radiotherapy resistance in lung cancer, WGCNA was conducted based on the DEGs from the TCGA cohort, stratified by the median FADS2 expression. This evidence concerns the gene FADS2 and lung carcinoma.